NCT00608699View on ClinicalTrials.gov

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Healthy SubjectsDyslipidaemias
Interventions
DRUG

GSK256073A tablets + IR niacin tablets

single dosing for 4 to 5 sessions

Trial Locations (1)

21225

GSK Investigational Site, Baltimore

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY